lobbying_activities: 591706
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 591706 | 125abcf5-b513-43df-b5c4-62c818e8fe3b | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | ASTELLAS PHARMA US | 2008 | first_quarter | PHA | Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatchwaxman Act; drug imporation; and drug safety | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-04-16T12:01:39-04:00 |